US$ 20.30
sglt2 inhibitors and glp 1 agonist SGLT-2 GLP-1 Agonists: First-Line Therapy for Diabetes With Established Cardiovascular Disease Criteria for recommendation of SGLT2
Description
Consequently, this prolongs the feeling of fullness (satiety), reduces appetite, and reduces overall calorie intake subsequently leading to negative energy balance and weight loss 18

Note that all prescriptions are at the discretion of your healthcare provider
Doctor-Led Treatment at Medi Clinic JB: Genuine medication sourced through authorised pharmaceutical channels

The research linking these ingredients to potential weight management and GLP-1 support is still in the early stages, and the studies that currently exist are quite small and not very robust, explains Lorenz

doi: 10.1002/oby.24002 [DOI] [PubMed] [Google Scholar] 5.Han SH, Safeek R, Ockerman K, et al

2022 Nov-Dec;103104 doi: 10.1016/j.nut.2022.111791
